Why the study?
Are Short Form (SF-36) Health Survey measures associated with nonadherence to antihypertensive medications in urban African Americans with severe, poorly controlled hypertension?
Are Short Form (SF-36) Health Survey measures associated with nonadherence to antihypertensive medications in urban African Americans with severe, poorly controlled hypertension?
Higher physical functioning, especially when combined with poor mental health, is associated with increased nonadherence to antihypertensive medications among urban African Americans.
Answers are grounded in this paper and cite their sources.
Higher PCS scores were associated with nonadherence; hypothesis-generating for SF-36 in adherence assessment among urban African Americans with severe hypertension.
The objective of this study was to determine whether an association exists between Short Form (SF-36) Health Survey measures and nonadherence among urban African Americans with poorly controlled hypertension. A total of 158 African Americans were admitted to an urban academic hospital for severe, uncontrolled hypertension. The main outcome measure was self-reported nonadherence to antihypertensive medications using a validated instrument. For every 10-point increase in Physical Component Summary (PCS) score, an individual was almost two times more likely to report being nonadherent (odds ratio, 1.94; 95% confidence interval, 1.30-2.90; P<.01). A significant interaction (P=.05) was observed between the physical functioning and mental health subscales. Individuals with high physical functioning and low mental health scores displayed the lowest adherence rate. These results suggest that high physical functioning, especially if associated with poor mental health, increases the likelihood of nonadherence to antihypertensive regimens among urban African Americans. The SF-36 may serve as an effective clinical tool that identifies patients at risk for nonadherence and, more importantly, may improve clinicians' understanding of nonadherence, allowing for discussions about antihypertensive medications to be tailored to individual patients.
No takes yet. Share an insight, caveat, or question.
Konerman et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: